Sumitomo Chemical India has announced its integrated financial results for the quarter and half-year ended September 30, 2025. Key highlights include a total income of ₹9,531.39 million for the quarter and ₹20,398.27 million for the half-year. The company’s results reflect a seasonal business performance with key changes due to shifts in business strategy in certain segments. A limited review report from BSR & Co. LLP is also included.
Financial Performance Highlights
Sumitomo Chemical India’s financial results for Q2 2026 and the first half of fiscal year 2026 show the following:
- Total Income (Q2): ₹9,531.39 million
- Total Income (H1): ₹20,398.27 million
- Profit Before Tax (Q2): ₹2,378.74 million
- Profit Before Tax (H1): ₹4,797.64 million
- Profit After Tax (Q2): ₹1,778.97 million
- Profit After Tax (H1): ₹3,577.03 million
Key Financial Figures (Standalone)
A summary of the standalone financial performance for the quarter ended September 30, 2025, compared to previous periods:
- Revenue from operations for Q2 stood at ₹9,144.44 million.
- Other income for Q2 was ₹386.95 million.
- Total expenses for Q2 amounted to ₹7,152.65 million.
- Earnings per share stood at ₹3.56 for the quarter.
Key Financial Figures (Consolidated)
The consolidated results provide an overview including subsidiaries:
- Total Revenue for Q2: ₹9,298.15 million
- Total Revenue for H1: ₹19,865.94 million
Operational Updates
The announcement details a change in the company’s distribution strategy for animal nutrition products in India. Due to a shift in the parent company’s strategy, the supply of these products has been discontinued, leading Sumitomo Chemical India to cease distribution in the Indian market. The impact on overall results is expected to be immaterial.
Audit and Review
The financial results have undergone review by the Audit Committee and subsequent approval by the Board of Directors on October 27, 2025. BSR & Co. LLP conducted a limited review and provided an unmodified opinion on the financial results.
Source: BSE